The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 579-590

  Simmons, Cameron P ^a   Thwaites, Guy E ^a   Quyen, Nguyen Than Ha ^a   Chau, Tran Thi Hong ^b   Mai, Pham Phuong ^b   Dung, Nguyen Thi ^b   Stepniewska, Kasia ^c   White, Nicholas J ^c   Hien, Tran Tinh ^b   Farrar, Jeremy ^a  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; T LYMPHOCYTE; TUBERCULOUS MENINGITIS;

EID: 21244456366     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.579     Document Type: Article

References (27)

1. Tsenova, L., A. Bergtold, V. H. Freedman, R. A. Young, and G. Kaplan. 1999. Tumor necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc. Natl. Acad. Sci. USA 96: 5657-5662.
2. Prasad, K., J. Volmink, and G. R. Menon. 2000. Steroids for treating tuberculous meningitis. Cochrane Database Syst. Rev. 3: CD002244.
3. O'Toole, R. D., G. F. Thornton, M. K. Mukherjee, and R. L. Nath. 1969. Dexamethasone in tuberculous meningitis: relationship of cerebrospinal fluid effects to therapeutic efficacy. Ann. Intern. Med. 70: 39-48.
4. Schoeman, I. F., L. E. Van Zyl, I. A. Laubscher, and P. R. Donald. 1997. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 99: 226-231.
5. Schoeman, J. F., J. W. Elshof, J. A. Laubscher, A. Janse van Rensburg, and P. R. Donald. 2001. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Ann. Trop. Paediatr. 21: 299-305.
6. Thwaites, G. E., D. B. Nguyen, H. D. Nguyen, T. Q. Hoang, T. T. Do, T. C. Nguyen, Q. H. Nguyen, T. T. Nguyen, N. H. Nguyen, T. N. Nguyen, et al. 2004. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N. Engl. J. Med. 351: 1741-1751.
7. Thwaites, G. E., C. P. Simmons, N. Than Ha Quyen, T. Thi Hong Chau, P. Phuong Mai, N. Thi Dung, N. Hoan Phu, N. P. White, T. Tinh Hien, and J. J. Farrar. 2003. Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis. J. Infect. Dis. 188: 1105-1115.
8. Umland, S. P., R. P. Schleimer, and S. L. Johnston. 2002. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm. Pharmacol. Ther. 15: 35-50.
9. Adcock, I. M. 2001. Glucocorticoid-regulated transcription factors. Pulm. Pharmacol. Ther. 14: 211-219.
10. Brattsand, R., and M. Linden. 1996. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol. Ther. 10(Suppl. 2): 81-90.
11. Dhabhar, F. S., and B. S. McEwen. 1999. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA 96: 1059-1064.
12. Wilckens, T., and R. De Rijk. 1997. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol. Today 18: 418-424.
13. Franchimont, D., H. Martens, M. T. Hagelstein, E. Louis, W. Dewe, G. P. Chrousos, J. Belaiche, and V. Geenen. 1999. Tumor necrosis factor a decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 84: 2834-2839.
14. Galon, J., D. Franchimont, N. Hiroi, G. Frey, A. Boettner, M. Ehrhart-Bornstein, J. J. O'Shea, G. P. Chrousos, and S. R. Bornstein. 2002. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16: 61-71.
15. Akalin, H., A. C. Akdis, R. Mistik, S. Helvaci, and K. Kilicturgay. 1994. Cerebrospinal fiuid interleukin-1γ/interleukin-1 receptor antagonist balance and tumor necrosis factor-γ concentrations in tuberculous, viral and acute bacterial meningitis. Scand. J. Infect. Dis. 26: 667-674.
16. Donald, P. R., J. F. Schoeman, N. Beyers, E. D. Nel, S. M. Carlini, K. D. Olsen, and G. H. McCracken. 1995. Concentrations of interferon γ, tumor necrosis factor α, and interleukin-1β in the cerebrospinal fiuid of children treated for tuberculous meningitis. Clin. Infect. Dis. 21: 924-929.
17. Glimaker, M., P. Kragsbjerg, M. Forsgren, and P. Olcen. 1993. Tumor necrosis factor-α (TNFα) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNFα indicate bacterial meningitis. J. Infect. Dis. 167: 882-889.
18. Mastroianni, C. M., F. Paoletti, M. Lichtner, C. D'Agostino, V. Vullo, and S. Delia. 1997. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin. Immunol. Immunopathol. 84: 171-176.
19. Bean, A. G., D. R. Roach, H. Briscoe, M. P. France, H. Korner, J. D. Sedgwick, and W. J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162: 3504-3511.
20. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254.
21. Cooper, A. M., A. Kipnis, J. Turner, J. Magram, J. Ferrante, and I. M. Orme. 2002. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168: 1322-1327.
22. Schoeman, J. F., P. Springer, A. J. van Rensburg, S. Swanevelder, W. A. Hanekom, P. A. Haslett, and G. Kaplan. 2004. Adjunctive trialidomide therapy for childhood tuberculous meningitis: results of a randomized study. J. Child. Neurol. 19: 250-257.
23. Raju, B., C. F. Tung, D. Cheng, N. Yousefzadeh, R. Condos, W. N. Rom, and D. B. Tse. 2001. In situ activation of helper T cells in the lung. Infect. Immun. 69: 4790-4798.
24. + T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood 88: 3513-3521.
25. - T cell subset contains specialized primed T cells. J. Immunol. 154: 17-25.
26. + T cells. J. Exp. Med. 194: 1711-1719.
27. Hill, P. C., R. H. Brookes, A. Fox, K. Fielding, D. J. Jeffries, D. Jackson-Sillah, M. D. Lugos, P. K. Owiafe, S. A. Donkor, A. S. Hammond, et al. 2004. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin. Infect. Dis. 38: 966-973.